UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

The Lancet (British edition), 2017-10, Vol.390 (10105), p.1843-1852

2017

Volltextzugriff (PDF)

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents

Journal of the American College of Cardiology, 2018-12, Vol.72 (25), p.3287-3297

2018

Volltextzugriff (PDF)

Is It That Difficult to Follow the Instructions?

Cardiovascular revascularization medicine, 2021-08, Vol.29, p.7-8

Koolen, Jacques J.

2021

Volltextzugriff (PDF)

Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial

JACC. Cardiovascular interventions, 2020-06, Vol.13 (11), p.1343

2020

Volltextzugriff (PDF)

What Would You Do, Doctor?

Cardiovascular revascularization medicine, 2021-02, Vol.23, p.20-21

Koolen, Jacques J.

2021

Volltextzugriff (PDF)

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

The Lancet (British edition), 2013-03, Vol.381 (9869), p.836-844

2013

Volltextzugriff (PDF)

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes

JACC. Cardiovascular interventions, 2022-09, Vol.15 (18), p.1852-1860

2022

Volltextzugriff (PDF)

Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus

The American journal of cardiology, 2019-10, Vol.124 (7), p.1020-1026

2019

Volltextzugriff (PDF)

Predictors of Coronary Stent Thrombosis : The Dutch Stent Thrombosis Registry

Journal of the American College of Cardiology, 2009-04, Vol.53 (16), p.1399-1409

2009

Volltextzugriff (PDF)

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

The Lancet (British edition), 2007-06, Vol.369 (9576), p.1869-1875

2007

Volltextzugriff (PDF)

Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial

JACC. Cardiovascular interventions, 2017-01, Vol.10 (2), p.133-143

2017

Volltextzugriff (PDF)

TCT-790 Efficacy and Safety of the Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents for Treatment of Patients With Diabetes Mellitus

Journal of the American College of Cardiology, 2018-09, Vol.72 (13), p.B315-B315

2018

Volltextzugriff (PDF)

Bioresorbable polymer drug-eluting stents – Authors' reply

The Lancet (British edition), 2018-03, Vol.391 (10124), p.936-937

2018

Volltextzugriff (PDF)

Pressure gradient vs. flow relationships to characterize the physiology of a severely stenotic aortic valve before and after transcatheter valve implantation

European heart journal, 2018-07, Vol.39 (28), p.2646-2655

2018

Volltextzugriff (PDF)

Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries

JACC. Cardiovascular interventions, 2009-04, Vol.2 (4), p.312-320

2009

Volltextzugriff (PDF)

A brief mindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: the MindfulHeart randomized controlled trial

Journal of behavioral medicine, 2014-02, Vol.37 (1), p.135-144

2014

Volltextzugriff (PDF)

TCT-91 Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Journal of the American College of Cardiology, 2018-09, Vol.72 (13), p.B39-B40

2018

Volltextzugriff (PDF)

TCT-195 Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Two-year Outcomes from the Randomized BIOFLOW V Trial

Journal of the American College of Cardiology, 2018-09, Vol.72 (13), p.B83-B83

2018

Volltextzugriff (PDF)

Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach

The American heart journal, 2017-11, Vol.193, p.35-45

2017

Volltextzugriff (PDF)

Vascular Tissue Reaction to Acute Malapposition in Human Coronary Arteries: Sequential Assessment With Optical Coherence Tomography

Circulation. Cardiovascular interventions, 2012-02, Vol.5 (1), p.20-29

2012

Volltextzugriff (PDF)

Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque?

Atherosclerosis, 2012-03, Vol.221 (1), p.106-112

2012

Volltextzugriff (PDF)

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association, 2021-06, Vol.10 (12), p.e019815-e019815

2021

Volltextzugriff (PDF)

Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up

Cardiovascular diabetology, 2017-02, Vol.16 (1), p.23-23, Article 23

2017

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(189)

Publikationsform

Sprache

Englisch
(210)

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(118)
Humans
(112)
Cardiovascular System & Cardiology
(105)
Cardiac & Cardiovascular Systems
(104)
Male
(90)
Female
(85)
Middle Aged
(85)
Aged
(69)
Treatment Outcome
(58)
Biological And Medical Sciences
(52)
Medical Sciences
(52)
Stents
(49)
Coronary Angiography
(46)
Cardiovascular
(44)
Drug-Eluting Stents
(41)
Absorbable Implants
(39)
Cardiology
(37)
Time Factors
(37)
Prosthesis Design
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents

Is It That Difficult to Follow the Instructions?

Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial

What Would You Do, Doctor?

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes

Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus

Predictors of Coronary Stent Thrombosis : The Dutch Stent Thrombosis Registry

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial

TCT-790 Efficacy and Safety of the Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents for Treatment of Patients With Diabetes Mellitus

Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?

Bioresorbable polymer drug-eluting stents – Authors' reply

Pressure gradient vs. flow relationships to characterize the physiology of a severely stenotic aortic valve before and after transcatheter valve implantation

Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries

A brief mindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: the MindfulHeart randomized controlled trial

TCT-91 Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

TCT-195 Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Two-year Outcomes from the Randomized BIOFLOW V Trial

Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach

Vascular Tissue Reaction to Acute Malapposition in Human Coronary Arteries: Sequential Assessment With Optical Coherence Tomography

Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque?

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents

Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up

Suchergebnisse filtern